• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

A Prospective Study on Upper Limb Supraclavicular Brachial Plexus Block: Dexmedetomidine with Ropivacaine and Dexamethasone with Ropivacaine and Ropivacaine Alone

    Dr. Sonik G. Shah, Dr. Mayur Vasava, Dr. Vipul M. Shah, Dr. Ramesh Solanki

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1772-1782

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction:
Pain is defined as “As unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Pain is an inevitable consequence of surgery. Surgical intervention done to reduce human suffering is associated with pain and distress to patients. Severe pain  causes increased stress response to surgery, seen as a cascade of endocrine, metabolic and inflammatory events that may contribute to organ dysfunction, morbidity, increased hospital stay and mortality.
Material and Methods: 
The present study from  May 2020  to March 2022 was conducted on 60 cases prospectively in patients admitted to the, Department of anaesthesia ,Dr. N.D. Desai FMSR, Dharmasinh Desai University, College Road, Nadiad, Gujrat, undergoing elective upper limb surgery. The inclusion and exclusion criteria, 60 ASA physical status I or II patients of either sex, aged 18-60 yrs  were randomly allocated in to 3 groups of 20 each.
Group I: Patients receiving 0.5% Ropivacaine (30ml) + Dexmedetomidine 50mcg (diluted to 2 ml).
Group II: Patients receiving 0.5% Ropivacaine (30ml) + Dexamethasone 8mg (2ml).
Group III: Patients receiving 0.5% Ropivacaine (30ml) + saline (2ml).
Under strict aseptic precautions, patients were given Ultrasound guided Supraclavicular brachial plexus block with any one of the study drugs .
Results: 
Demographic data(age ,sex distribution ,weight) and surgical characteristics (duration of surgery and type of surgery) were similar in all the 3 groups.
ONSET OF SENSORY AND MOTOR BLOCKADE : The mean time for onset of sensory block in group I was 7.45±1.10 min and in group II was 10.15 ± 1.14 min and group III was 12.45±2.76 . The mean time for onset of motor block  in  group I was 10.60 ± 1.05 min and in  group II was 14.95 ± 0.83 min and and  group III was 16.05 ± 1.96. 
The onset of sensory and motor  block was significantly early in Dexmedetomidine group (group I) i.e, 7.45±1.10 min followed by dexamethasone group (group II) as compared   to plain Ropivacaine group (group III).
DURATION OF SENSORY AND MOTOR BLOCKADE: The total duration of sensory block  in  group I was 768±25.52  min and in group II was 909±22.10 min and in group III was 450±27.74 min.   The  duration of motor block in group I is 717.50±22.09  min and in group II was 878±19.47 min and in group III was 420±23.17 min. 
There is significant difference in the total duration of sensory and  motor block between the three groups. (P <0.001).The duration sensory and motor blockade is longest in Dexamethasone group followed by Dexmedetomidine group as compared to the control group Ropivacaine alone.
Conclusion: 
We conclude that although both Dexmedetomidine and Dexamethasone are better adjuvants to Ropivacaine as compared to Ropivacaine alone  in Supraclavicular Brachial block , Dexamethasone is a better choice in terms of  prolonging the  duration of sensory and motor blockade and duration of analgesia,  followed by Dexmedetomidine than Ropivacaine alone.
Keywords:
  • PDF (389 K)
  • XML
(2022). A Prospective Study on Upper Limb Supraclavicular Brachial Plexus Block: Dexmedetomidine with Ropivacaine and Dexamethasone with Ropivacaine and Ropivacaine Alone. European Journal of Molecular & Clinical Medicine, 9(2), 1772-1782.
Dr. Sonik G. Shah, Dr. Mayur Vasava, Dr. Vipul M. Shah, Dr. Ramesh Solanki. "A Prospective Study on Upper Limb Supraclavicular Brachial Plexus Block: Dexmedetomidine with Ropivacaine and Dexamethasone with Ropivacaine and Ropivacaine Alone". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1772-1782.
(2022). 'A Prospective Study on Upper Limb Supraclavicular Brachial Plexus Block: Dexmedetomidine with Ropivacaine and Dexamethasone with Ropivacaine and Ropivacaine Alone', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1772-1782.
A Prospective Study on Upper Limb Supraclavicular Brachial Plexus Block: Dexmedetomidine with Ropivacaine and Dexamethasone with Ropivacaine and Ropivacaine Alone. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1772-1782.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 59
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus